ROS1 immunohistochemistry as a potential predictive biomarker for ROS1-targeted therapy in breast cancer: impact of antibody clone selection

Anna Sokolova(The University of Queensland), Amy E. McCart Reed(The University of Queensland)
medRxiv
December 10, 2024
Cited by 0


Related Papers